Drug intelligence / Profile preview

nimorazole

Development stage
Phase 3
Lead developer
Norgine
Modality
Small Molecules
Administration
Oral
01

Overview

Nimorazole is a synthetic 5-nitroimidazole compound with antimicrobial activity against anaerobic bacteria and protozoa, similar to metronidazole. It also acts as a radiosensitizer by mimicking oxygen, thereby inducing free radical formation and sensitizing hypoxic tumor cells to the cytotoxic effects of ionizing radiation. Nimorazole has been used in the treatment of infections such as trichomoniasis, amoebiasis, giardiasis, and acute ulcerative gingivitis. In oncology, it is primarily investigated for use alongside radiotherapy in head and neck squamous cell carcinoma (HNSCC), where it selectively targets hypoxic tumor cells that are otherwise resistant to radiation[1][2][3][4][6]. Its use as a radiosensitizer has shown improved locoregional control in clinical trials for head and neck cancers[6].

Brand names
NaxoginNulogyl
Other names
EsclamaNitrimidazine

Beyond the preview

Go deeper on nimorazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nimorazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call